(HealthDay)—High-flow oxygen therapy may be more effective than standard oxygen therapy in preventing care escalation among infants with bronchiolitis treated outside an intensive care unit, according ...

Among ICU patients with acute hypoxemic respiratory failure, high-flow nasal oxygen reduced the incidence of intubation but did not significantly reduce 28-day mortality compared with standard oxygen ...

High-flow oxygen therapy through a nasal cannula has been increasingly used in infants with bronchiolitis, despite limited high-quality evidence of its efficacy. The efficacy of high-flow oxygen ...

The conclusion was that titrating oxygen administration to adequate levels, as recommended in guidelines, [1] is safer than administering oxygen at high flow rates to patients with COPD who may have ...

High-flow nasal oxygen (HFNO) is noninferior to noninvasive ventilation (NIV) for endotracheal intubation or death within seven days for most patients with acute respiratory failure, according to a ...

Increased respiratory patient illness, COVID-19, and product recalls have created a critical need for ventilators in the United States, said David Shockley, Movair’s CEO, in a recent company press ...

To the Editor: Frat and colleagues (June 4 issue) 1 report a survival benefit with high-flow oxygen, as compared with standard oxygen or noninvasive ventilation, in patients with acute hypoxemic ...

Children, as well as their parents, may one day be able to breathe a little easier: The respiratory therapy company Vapotherm said a pilot study of its high-flow treatment showed it could outperform ...

In a large randomized trial, treating patients with acute hypoxemic respiratory failure with high-flow oxygen didn't improve survival compared with standard oxygen. However, high-flow oxygen did ...

Hypoxemia is the most common complication of emergency endotracheal intubation of children, with an incidence of up to 50%. In this randomized trial of children under 16 years, nasal high-flow oxygen ...